Akèy › Neuroblastom
Etid klinik pou Neuroblastom ap rekrite nan Etazini
47 etid pou Neuroblastom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA13 etid
- Washington, DC11 etid
- New York City, NY10 etid
- Philadelphia, PA9 etid
- Dallas, TX9 etid
- Memphis, TN9 etid
- St. Louis, MO9 etid
- Hartford, CT8 etid
- Aurora, CO8 etid
- Birmingham, AL8 etid
- Minneapolis, MN8 etid
- Atlanta, GA7 etid
- San Francisco, CA7 etid
- Cincinnati, OH7 etid
- Los Angeles, CA7 etid
- Orlando, FL7 etid
- Miami, FL7 etid
- Houston, TX7 etid
- Seattle, WA6 etid
- Gainesville, FL6 etid
- Chicago, IL6 etid
- Honolulu, HI6 etid
- Harrisburg, PA6 etid
- Little Rock, AR6 etid
- Durham, NC6 etid
- Greenburgh, NY6 etid
- Portland, OR6 etid
- Salt Lake City, UT6 etid
- Ann Arbor, MI5 etid
- Columbus, OH5 etid
- Nashville, TN5 etid
- Mountain View, CA5 etid
- San Diego, CA5 etid
- Austin, TX5 etid
- Oakland, CA5 etid
- Fort Worth, TX4 etid
- Clifton, NJ4 etid
- Edison, NJ4 etid
- Louisville, KY4 etid
- Charlotte, NC4 etid
Pa eta
- Alabama8 etid
- Arizona3 etid
- Arkansas6 etid
- Ayiti6 etid
- Colorado8 etid
- Connecticut9 etid
- Distrik Columbia6 etid
- Florid9 etid
- Georgia9 etid
- Illinois6 etid
- Indiana3 etid
- Iowa3 etid
- Kalifòni14 etid
- Kentucky5 etid
- Maryland8 etid
- Massachusetts13 etid
- Michigan8 etid
- Minnesota9 etid
- Missouri10 etid
- New Jersey6 etid
- New York13 etid
- North Carolina7 etid
- North Dakota3 etid
- Ohio8 etid
- Oregon6 etid
- Pennsylvania14 etid
- Rhode Island3 etid
- South Carolina4 etid
- South Dakota3 etid
- Tennessee12 etid
- Texas15 etid
- Utah6 etid
- Virginia3 etid
- Washington6 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
MCT for the Harvard/UCSF ROBIN Center
Ap rekrite
Tout laj · Tout sèks · Mizajou Oct 1, 2026 · NCT06000787A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Ap rekriteFaz 2Volontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 30, 2026 · NCT04936529Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks · Tout sèks · Mizajou Sep 28, 2026 · NCT01109394Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Sep 24, 2026 · NCT06172296Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
Ap rekriteFaz 1
Laj 3 a 35 · Tout sèks · Mizajou Sep 24, 2026 · NCT06995872Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01005654Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103Biomarkers of Resiliency In Childhood Cancer Surgery
Ap rekriteEtid obsèvasyon
Laj 3 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Ap rekriteFaz 2
Jiska laj 22 · Tout sèks · Mizajou Sep 4, 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 3, 2026 · NCT03088020Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Ap rekriteFaz 2
Laj 1 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT06540963B7-H3.CD28Z.CART in Solid Tumors
Ap rekriteFaz 1
9 Months – 30 Years · Tout sèks · Mizajou Sep 3, 2026 · NCT07358260Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Ap rekriteFaz 1/2
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Ap rekriteFaz 2
18 Months – 19 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT06528496Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
Ap rekriteFaz 2
Laj 1 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT07635056Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Ap rekriteFaz 1
Laj 1 a 23 · Tout sèks · Mizajou Aug 13, 2026 · NCT07172958Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Ap rekriteFaz 2
12 Months – 21 Years · Tout sèks · Mizajou Aug 12, 2026 · NCT05489887SPEARHEAD-3 Pediatric Study
Ap rekriteFaz 1/2
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT06057948PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Ap rekriteFaz 1/2
Laj 1 a 30 · Tout sèks · Mizajou Jul 22, 2026 · NCT06721689NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
Ap rekriteFaz 1
Laj 1 a 24 · Tout sèks · Mizajou Jul 21, 2026 · NCT07211737NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Ap rekriteFaz 2
Laj 1 a 31 · Tout sèks · Mizajou Jul 20, 2026 · NCT06450041Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.